jp morgan glp-1 Unpacking the Hype JPMorgan Predicts 45% Rally for

In humans, DPP-4is, including sitagliptin, have demonstrated a significant ability to decrease systemic inflammatory mediators such as CRP and IL-6 in patients with T2DM [82]

Por este efecto, es muy importante individualizar segn riesgo-beneficio

DuMouchel, W

HW TIPS TO MINIMIZE GI SIDE EFFECTS One or more gastrointestinal (GI) side effects are observed in roughly 10% to 50% of people who take one of these weight management medications.1,2 From nausea and vomiting to acid reflux, bloating, stomach cramps, diarrhea, and/or constipation, patients can minimize GI side effects with a start low, go slow approach, starting with the lowest dose and titrating as recommended (see table Currently FDA-Approved Mono and Dual Agonists)

These data emphasize the importance of monitoring UACR on treatment for prognosis

& Sharma, K